Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,272 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07449949Enrolling by invitation
Sequential chemoradiation and surgery for nasal rhabdomyosarcoma
This trial tests a treatment plan of chemotherapy, radiation, and then surgery for adults with rhabdomyosarcoma in the nose or sinus cavities. It aims to see if this sequence helps control the cancer.
Shanghai, ChinaAges 18–70 - NCT07450846Recruiting
Heart-lung interaction in severe breathing problems
This study looks at how the heart and lungs interact in patients with acute respiratory distress syndrome (a severe lung condition) who are on a breathing machine. Researchers will use ultrasound to check heart function at different times during treatment.
Le Kremlin-BicêtreAges 18 years+ - NCT07450898Recruiting
Pancreatitis after blood clot removal procedure
This study looks at people who developed pancreatitis after a blood clot removal procedure. The goal is to understand what might have caused the pancreatitis.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07448233Enrolling by invitation
AI health management for epilepsy in rural areas
This trial tests a smartphone-based AI system to help manage epilepsy long-term in rural areas. It is for people who have had at least one convulsive seizure in the past year and can use a smartphone with a caregiver.
Xi'an, ShaanxiAges 18–65 - NCT07453368RecruitingPhase 2
Orelabrutinib for relapsed or hard-to-treat AIHA
This trial tests a targeted pill called orelabrutinib for people with autoimmune hemolytic anemia (AIHA) that has come back or not responded to standard treatments. It may help control your immune system's attack on your red blood cells.
Beijing, Beijing MunicipalityAges 18–85 - NCT07450105Enrolling by invitation
Intensive DBT for Teens Who Self-Harm or Feel Suicidal
This study tests whether an intensive type of therapy called dialectical behavior therapy (DBT) can help teenagers who are hurting themselves or feeling suicidal. It focuses on young people with signs of borderline personality disorder, and includes parents or caregivers in the treatment.
BergenAges 14–17 - NCT07449897Recruiting
Gallstone removal during gallbladder surgery study
This study tests a method to remove bile duct stones during gallbladder surgery, aiming to treat both problems in one procedure.
OsloAges 18 years+ - NCT07445048RecruitingPhase 3
Radiation, targeted therapy, and immunotherapy for high-risk head and neck cancer
This trial tests if adding a targeted drug (nimotuzumab) and an immunotherapy (benmelstobart) after surgery and radiation can help prevent cancer from returning in patients with high-risk head and neck cancer who cannot take cisplatin chemotherapy.
ShanghaiAges 18 years+ - NCT07447596Recruiting
Lung health study using breathing tests and AI
This study uses a simple breathing test called oscillometry along with machine learning to better understand lung conditions like COPD, asthma, and interstitial lung disease. It may help find new ways to diagnose and track these diseases.
BarcelonaAges 18–99 - NCT07446374Recruiting
Maternal support services for new mothers
This study offers community-based support services for people who are pregnant or have recently given birth and receive care at Women and Infants Hospital. It aims to help mothers and their families during the perinatal period.
Pawtucket, Rhode IslandAges Any age - NCT07448077RecruitingPhase 2
Short radiation with immunotherapy for rectal cancer
This trial tests a combination of short-course radiation, chemotherapy, and an immunotherapy drug (Enlonstobart) for patients with a specific type of rectal cancer called pMMR. It aims to see if this approach can shrink tumors before surgery and improve outcomes.
Shijiazhuang, HebeiAges 18 years+ - NCT07450729Recruiting
IV catheter use study in children in the ER
This study looks at how IV catheters work in children who come to the emergency room and need an IV for at least 24 hours. It will help doctors understand the best ways to use and care for IVs in kids.
FlorenceAges birth–18 years - NCT07449793Recruiting
PBC treatment response and long-term health outcomes
This research study tracks how well Primary Biliary Cholangitis (PBC) responds to standard medication (UDCA) and what happens to patients' health over time. It may help doctors understand which treatments work best for different people.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07444801Recruiting
Tralokinumab for eczema with genital symptoms
This trial tests if tralokinumab, a drug already approved for moderate-to-severe eczema, helps people who also have eczema in the genital area. It aims to understand how well the drug works for this specific symptom.
Augsburg, MünchenAges 18 years+ - NCT07450092Enrolling by invitation
Prehospital use of forced air warming
This trial tests if using a forced air warming blanket before reaching the hospital can help healthy adults. It aims to see if keeping people warm during transport improves outcomes.
BergenAges 18–45 - NCT07444788RecruitingPhase 1
Acute effects of 5-MeO-DMT in healthy people
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
Basel, Canton of Basel-CityAges 25–65 - NCT07452003Recruiting
Immunotherapy plus chemo before and after lung cancer surgery
This trial tests a new combination of an immunotherapy drug (QL1706) plus chemotherapy given before and after surgery for people with certain stages of non-small cell lung cancer (NSCLC). The goal is to see if this approach helps shrink the tumor and improves outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07444931Recruiting
Predicting cardiac arrest risk in heart disease patients
This study looks at factors that may help predict sudden cardiac arrest in people with coronary artery disease. If you have a recent diagnosis of significant blockage or a heart attack, joining this trial could help improve risk assessment.
HaderaAges 18–75 - NCT07452848Recruiting
Pringle maneuver's effect on gallbladder after liver surgery
This trial studies whether a technique called the Pringle maneuver (temporarily stopping blood flow to the liver during surgery) affects gallbladder health after liver surgery. It is for people having a liver tumor removed while keeping their gallbladder.
Hefei, AnhuiAges 18–85 - NCT07450014Recruiting
Does anxiety before surgery affect risks from spinal anesthesia?
This study looks at whether how anxious you feel before surgery affects your risk of a sudden drop in heart rate and blood pressure (vasovagal event) when you receive spinal anesthesia. Participation may help doctors better understand and prevent these episodes.
SanliurfaAges 18–65 - NCT07446712Recruiting
Oxygen Therapy for Complex Regional Pain Syndrome
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) can help reduce pain from Complex Regional Pain Syndrome (CRPS) Type I. If you have this condition, the therapy may improve your symptoms.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT07453017Recruiting
Electrical impedance tomography for pulmonary hypertension
This study tests a new, noninvasive way to measure lung function in people with pulmonary hypertension (high blood pressure in the lungs). It uses a belt with electrodes placed around your chest during a standard heart catheterization procedure.
São Paulo, São PauloAges 18 years+ - NCT07450040Enrolling by invitation
Tislelizumab plus chemo for early-stage NK/T-cell lymphoma
This trial tests a combination of the immunotherapy drug tislelizumab with two chemotherapy drugs (gemcitabine and peraspartase) for people with newly diagnosed stage I or II NK/T-cell lymphoma. The goal is to see if this combination works well and is safe.
Shanghai, ChinaAges 18–70 - NCT07451652RecruitingPhase 2
Low dose epcoritamab plus chemotherapy for relapsed lymphoma
This trial tests a combination of a lower dose of the immunotherapy drug epcoritamab with standard chemotherapy (GemOx) for people with a type of lymphoma called DLBCL that has come back or not responded to previous treatment. The goal is to see if this combination can help get the lymphoma under control before a stem cell transplant (using your own cells).
Monterrey, Nuevo LeónAges 18–65
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,272 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.